IP Library Granted Patent US 7,671,183
Granted Patent B2
US 7,671,183 · App. 11/496,017 · Granted Mar 2, 2010

PAAD domain-containing polypeptides, encoding nucleic acids, and methods of use

Assignee: Burnham Institute for Medical Research
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,671,183
App. No.
11/496,017
Granted
Mar 2, 2010
Kind
B2
Abstract

The invention provides isolated nucleic acid molecules encoding PAAD-domain containing polypeptides and functional fragments thereof, including fragments containing PAAD domains, NACHT domains and ARED domains, encoded polypeptides, and antibodies. Also provided are methods of identifying polypeptides and agents that associate with a PAAD-domain containing polypeptide or fragment thereof, or that alter an association of a PAAD domain-containing polypeptides. Further provided are methods of identifying agents that modulate PAAD domain-mediated inhibition of NF K B activity, or modulate an activity of a NACHT domain of a PAAD domain-containing polypeptide. Also provided are methods of modulating NF K B transcriptional activity in a cell, and methods of altering expression of a PAAD domain-containing polypeptide in a cell.

Claims (9)

1. An isolated nucleic acid molecule consisting of a nucleic acid sequence selected from the group consisting of nucleotides 583-1545 of SEQ ID NO:65, nucleotides 607-1569 of SEQ ID NO:19, nucleotides 496-1446 of SEQ ID NO:83, nucleotides 745-1707 of SEQ ID NO:67, nucleotides 511-1452 of SEQ ID NO:69, nucleotides 613-1575 of SEQ ID NO:71, nucleotides 628-1602 of SEQ ID NO:73, nucleotides 499-1561 of SEQ ID NO:75, or a degenerate variant of any of said nucleic acid sequences, wherein said nucleic acid sequences encode the NACHT domain amino acid sequences SEQ ID NOS:107, 110, 113, 116, 119, 122, 125, 128, respectively.

2. The isolated nucleic acid molecule of claim 1 , wherein said amino acid sequence is SEQ ID NO: 107.

3. The isolated nucleic acid molecule of claim 1 , wherein said amino acid sequence is SEQ ID NO: 110.

4. The isolated nucleic acid molecule of claim 1 , wherein said amino acid sequence is SEQ ID NO:113.

5. The isolated nucleic acid molecule of claim 1 , wherein said amino acid sequence is SEQ ID NO:116.

6. The isolated nucleic acid molecule of claim 1 , wherein said amino acid sequence is SEQ ID NO:119.

7. The isolated nucleic acid molecule of claim 1 , wherein said amino acid sequence is SEQ ID NO: 122.

8. The isolated nucleic acid molecule of claim 1 , wherein said amino acid sequence is SEQ ID NO: 125.

9. The isolated nucleic acid molecule of claim 1 , wherein said amino acid sequence is SEQ ID NO: 128.

Assignments (4)
CONFIRMATORY LICENSE Recorded Mar 5, 2024
From: SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE
To: NATIONAL INSTITUTES OF HEALTH - DIRECTOR DEITR; THE NATIONAL SCIENCE FOUNDATION
Reel/Frame 066656/0034 →
CONFIRMATORY LICENSE Recorded Feb 8, 2024
From: SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE
To: NATIONAL INSTITUTES OF HEALTH - DIRECTOR DEITR
Reel/Frame 066421/0431 →
CONFIRMATORY LICENSE Recorded Nov 21, 2023
From: SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE
To: NATIONAL INSTITUTES OF HEALTH - DIRECTOR DEITR
Reel/Frame 065636/0710 →
CHANGE OF NAME Recorded Jan 13, 2010
From: THE BURNHAM INSTITUTE
To: BURNHAM INSTITUTE FOR MEDICAL RESEARCH
Reel/Frame 023775/0534 →
Continuity (3)
Division 1040786600 · Apr 4, 2003
Provisional Application 6037053800 · Apr 4, 2002
Related Publication 20070020708A1 · Jan 25, 2007